KangaBio
Shanghai
About KangaBio
KangaBio is a biotech business specializing in developing novel medicines to meet unmet medical needs. It helps in developing prodrugs of immune-stimulating medicines and other multi-specific biologics to minimize toxicities and boost treatment efficacy for already established targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.9M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: kangabio.com
Industries & Categories
Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/kangabio-132007 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.